BRIEF published on 05/07/2025 at 14:41, 1 year 1 month ago Changement de direction chez Carl Zeiss Meditec AG Changement De Direction Carl Zeiss Meditec AG Maximilien Foerst Stabilité De La Gestion Marché De La Grande Chine
BRIEF published on 05/07/2025 at 14:41, 1 year 1 month ago Leadership Change at Carl Zeiss Meditec AG Carl Zeiss Meditec AG Leadership Change Maximilian Foerst Management Stability Greater China Market
PRESS RELEASE published on 05/07/2025 at 14:36, 1 year 1 month ago EQS-Adhoc: Change of President and CEO at Carl Zeiss Meditec AG Carl Zeiss Meditec AG announces change of President and CEO, Dr. Markus Weber, to be succeeded by Maximilian Foerst. Handover on May 31, 2025. Foerst appointed as new Executive Board member of Carl Zeiss AG Carl Zeiss Meditec AG President CEO Change Maximilian Foerst
BRIEF published on 04/15/2025 at 09:02, 1 year 2 months ago Carl Zeiss Meditec annonce de solides résultats au deuxième trimestre 2024/25 Croissance Des Revenus Marché Chinois Chirurgie Réfractive Résultats Du Deuxième Trimestre 2024/25 Augmentation De L'EBITA
BRIEF published on 04/15/2025 at 09:02, 1 year 2 months ago Carl Zeiss Meditec Reports Strong Q2 Earnings for 2024/25 Revenue Growth Refractive Surgery China Market Q2 2024/25 Earnings EBITA Increase
PRESS RELEASE published on 04/15/2025 at 08:57, 1 year 2 months ago EQS-Adhoc: Carl Zeiss Meditec achieves significant earnings increase in Q2 2024/25 Carl Zeiss Meditec AG achieves significant earnings increase in Q2 2024/25, with revenue of EUR 560 million and EBITA of EUR 78 million Revenue Growth Carl Zeiss Meditec AG Earnings Increase EBITA Q2 2024/25
BRIEF published on 02/27/2025 at 10:43, 1 year 3 months ago Le ZEISS VISUMAX 800 obtient l'approbation de la Chine Marché Chinois Approbation Réglementaire ZEISS VISUMAX 800 Laser Femtoseconde Amélioration Chirurgicale
BRIEF published on 02/27/2025 at 10:43, 1 year 3 months ago ZEISS VISUMAX 800 Gains China Approval Regulatory Approval China Market ZEISS VISUMAX 800 Femtosecond Laser Surgical Enhancement
PRESS RELEASE published on 02/27/2025 at 10:38, 1 year 3 months ago ZEISS VISUMAX 800 with SMILE pro software receives approval in China ZEISS VISUMAX 800 with SMILE pro software receives approval in China, providing faster treatment, flexibility, and workflow enhancements for refractive surgeons ZEISS VISUMAX 800 Femtosecond Laser SMILE Pro Software China Approval Refractive Surgeons
BRIEF published on 02/12/2025 at 07:03, 1 year 4 months ago Carl Zeiss Meditec Reports Modest Revenue Growth for Q1 2024/25 Revenue Growth Carl Zeiss Meditec Ophthalmology Q1 2024/25 Global Performance
Published on 06/26/2026 at 14:05, 2 hours 18 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 2 hours 23 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 3 hours 23 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 3 hours 38 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 15:30, 53 minutes ago JMGO Extends Special Savings Beyond Prime Day with N3 Ultimate at Its Best Price Since Launch
Published on 06/26/2026 at 15:23, 1 hour ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 06/26/2026 at 15:22, 1 hour 1 minute ago Form 8.3 - The Vanguard Group, Inc.: Senior plc
Published on 06/26/2026 at 15:21, 1 hour 2 minutes ago Form 8.3 - The Vanguard Group, Inc.: SEGRO plc
Published on 06/26/2026 at 07:00, 9 hours 23 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 9 hours 23 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
